Attana increases focus on customer-centric operations
Attana implements organizational changes to ensure more customer-centric operations and an increased focus on sales within all business functions.
Attana has during the year continued to optimize the organization and deepen strategic collaborations with the goal of focusing the company's resources on key customers. Technical development continues to be performed in close collaboration with select customers and partners under the management of Attana personnel. The organizational changes are summarized below:
Life Science - The company's key customers have been allocated a dedicated Attana account manager and sales partners/distributors will primarily focus on lead generation.
Diagnostics - The business unit prioritizes sales through distributors and strategically important customers and Samir Fostock reverts to an external advisory role.
Product – A product manager has been appointed to ensure optimized resource allocation. Various product functions, e.g. software, hardware and applications have a dedicated internal Attana resource as well as one or more external partners.
Instrument Service - A service manager has been appointed with responsibility for generating increased sales and ensuring the company's commitments to our customers and distributors.
Production - As previously communicated, Attana plans to move the production of consumables such as sensor chips and reagents to AroCell. The purpose of the move is to improve production capacity with better profit margins. Production of Instruments remains with Attana.
Teodor Aastrup, CEO Attana, comments:
“During the pandemic, we experienced that stable conditions are more important than ever in achieving commercial success. We have been successful in deals where we have built a strong customer relationship, and with these organizational adjustments intend to strengthen and develop existing customer relationships for increased revenue.”
For more information, please contact:
Teodor Aastrup, CEO
teodor.aastrup@attana.com
+46 (0)8 674 57 00
The Board of directors for Attana consider that the information in this press release is not likely to have a significant effect on the share price but is of general interest for the shareholders and hence should be communicated.
About Attana
Attana was founded in 2002 with the vision of in vitro characterization of molecular interactions mimicking in vivo conditions. Since then, Attana has developed proprietary label free biosensors for biochemical, crude, sera, and cell-based assays and the Attana Virus Analytics (AVA) platform, a proprietary in vitro diagnostics (IVD) tool. Attana products and research services are used by Big Pharma, biotech companies and academic institutions within the life sciences. To learn more about our latest services and products, please visit www.attana.com or contact sales@attana.com
Tags: